Get started
Author

Shaykhah Alotaibi

Observed names: Shaykha Alotaibi, Shaykhah AlOtaibi, Shaykhah Mujahhiz Alotaibi
ORCID: 0000-0002-8134-8644
Observed ORCID: 0000-0002-8134-8644
OpenAlex ID: A5114036052
Current Status of CPX-351 Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
2022 · Shaykhah Alotaibi, Dietger Niederwieser, et al. · Clinical Lymphoma Myeloma & Leukemia · 8
Mechanistic basis and therapeutic modulation of T cell fitness to enhance CAR-T cell efficacy in hematological malignancies
2026 · Karama Makni-Maalej, Shaykhah Mujahhiz Alotaibi, et al. · Frontiers in Immunology · 4
PDF
Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle east
2025 · Amr Hanbali, Fahad Bahkali, et al. · Cytotherapy · 3
Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?
2023 · Razan Mohty, Shaykha Alotaibi, et al. · Clinical Hematology International · 3
PDF
Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients
2022 · Afnan Al-Sabbagh, Hazza Alzahrani, et al. · Blood · 2
Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia
2025 · Bandar Al-Judaibi, Hazzaa Alzahrani, et al. · Saudi Journal of Gastroenterology · 1
Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study
2024 · Nourah Alzaidy, Chokri Ben Lamine, et al. · Blood · 1
Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia
2024 · Khalid Alsuhaibani, Amal Hejab, et al. · Blood · 1
PDF
Safety of tyrosine kinase inhibitors during pregnancy in chronic myeloid leukemia: a 15-year single-center analysis
2026 · Chokri Ben Lamine, Nourah Alzaidy, et al. · Blood Global Hematology
Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT: a 20-year single-center experience
2026 · Alfadil Haroon, Hazzaa Alzahrani, et al. · Blood Research
PDF
Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study
2026 · Khalid Alsuhaibani, Amal Hejab, et al. · Cytotherapy
Transplant outcomes in adolescents and young adults with Philadelphia‐positive B‐cell acute lymphoblastic leukaemia
2026 · Manar Aleid, Riad El Fakih, et al. · British Journal of Haematology
Supportive Care in Severe and Very Severe Aplastic Anemia
2026 · Britta Höchsmann, Mahmoud Aljurf, et al. · Springer eBooks
PDF
Immune tolerance induction after haploidentical stem cell transplant following organ transplantation in sickle cell disease
2025 · Ali Alahmari, Saad Alghamdi, et al. · Blood
PDF
Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT
2025 · Alfadil Haroon, Riad El Fakih, et al. · Blood
Sickle cell hepatopathy in Oman: An emerging burden demanding regional action
2025 · Bandar Al-Judaibi, Ibrahim Alrajhi, et al. · Saudi Journal of Gastroenterology
Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East
2025 · Amr Hanbali, Ayman Saad, et al. · Clinical Lymphoma Myeloma & Leukemia
Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience
2025 · Riad El Fakih, Mohamed I. Sharif, et al. · Bone Marrow Transplantation
Impact of Extranodal Involvement on Outcomes with Chimeric Antigen Receptor T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma
2024 · Vinod Kumar, Shaykhah Alotaibi, et al. · Blood
PDF
Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia
2024 · Amal Hejab, Khalid Alsuhaibani, et al. · Blood
Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia
2024 · Nourah Alzaidy, Mostafa Faisal Mohammed Saleh, et al. · Blood
The Impact of Pre-Existing Autoimmune Disease on the Safety and Efficacy of CAR T-Cell Therapy for Non-Hodgkin Lymphoma
2023 · Charles Gaulin, Shaykhah Alotaibi, et al. · Blood
PDF
Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia
2021 · Ahmad S. Alotaibi, Shad Ahmed, et al. · Blood
Works count: 23
Citation count: 23
H-index: 3
I10-index:
Year
Topic
Type